Mechanistically, the targeting of METTL3 suppressed MDSC infiltration in a CRC microenvironment, which unleashed an anti-PD1-mediated CD8+ T cell antitumor response [77]. This evidence concerns the gene METTL3 and colorectal carcinoma.